The secondaries market anticipates 2024 will be a record year for volume, with first-half figures coming in at between $68bn and $72bn.
4 min read · 30 December 2024
The $1.2bn secondaries transaction involves R1 RCM, a healthcare sector revenue cycle management services provider.
2 min read · 20 December 2024
The firm has temporarily delayed capital raising for GP Equity Solutions and is instead focusing on dealmaking, Secondaries Investor has learned.
2 min read · 19 December 2024
The deal marks the first continuation vehicle for Guardian Capital Partners.
2 min read · 18 December 2024
Swiss GP Gyrus Capital originally invested in Essential Pharma in 2019 as part of a family/founder succession plan process.
2 min read · 11 December 2024
Advent is seeking to move business management software, payments and commerce-related technologies provider Xplor into a separate vehicle.
2 min read · 28 November 2024
Pursuing both strategies via a single fund allows for better market timing and greater diversification, according to Montana Capital’s Marco Wulff and Eduard Lemle.
2 min read · 25 November 2024
Some of the secondaries market’s biggest buyers have committed LP capital to Accel-KKR’s debut blindpool secondaries fund. What gives?
3 min read · 22 November 2024
Ardian, StepStone, Adams Street Partners and CPP Investments are LPs in the firm’s debut buyside fund.
3 min read · 21 November 2024
Milan-based Ambienta is seeking a single-asset continuation fund, which will be classified as an Article 9 vehicle under the EU’s SFDR, Secondaries Investor has learned.
2 min read · 19 November 2024